Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2005
11/30/2005EP1599878A1 Optical recording materials having high storage density
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599467A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP1599451A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
11/30/2005EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
11/30/2005EP1124827B1 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005CN1703413A Thiadiazole compound and use thereof
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703411A Piperidine derivatives as CCR5 inhibitors
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703259A Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof
11/30/2005CN1703220A Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229359C Catalytic process for prepn. of thiazole derivatives
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969766 PNA monomer and precursor
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2318160C Asymmetric cyanine dye quenchers
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005111032A1 New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indl-2-one hydrochloride) and process to produce the same
11/24/2005WO2005111031A2 Neuropeptide receptor modulators
11/24/2005WO2005111029A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005WO2005111025A1 3-piperidinylisochroman-5-ols as dopamine agonists
11/24/2005WO2005111023A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111016A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111014A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
11/24/2005WO2005111007A1 Thiazole compound and use thereof
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110987A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005WO2005110980A2 Aryl sulfones and uses related thereto
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005110406A2 Phenyl derivatives for the treatment of abnormal cell growth
11/24/2005WO2005085198A3 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/24/2005WO2005084222A3 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005WO2005076990A3 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
11/24/2005WO2005068458A3 Five-membered heterocyclic compounds as inhibitors of src family protein kinase
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261325 Gamma-aminoamide modulators of chemokine receptor activity
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261311 Piperizinones as modulators of chemokine receptor activity
11/24/2005US20050261310 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261304 1,3-benzothiazol-2-yl[2-({4-[(4-methylpiperazin-1-yl)methyl]benzyl}oxy)pyrimidin-4-yl]acetonitrile; crosses the Blood brain barrier
11/24/2005US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants
11/24/2005US20050261294 Substituted heteroaryl derivatives, compositions, and methods of use
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261289 4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2566707A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2566625A1 Thiazole compound and use thereof
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2565953A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2565186A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
11/24/2005CA2564751A1 Neuropeptide receptor modulators
11/24/2005CA2564207A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005CA2564199A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2563607A1 4,5-disubstituted-2-aryl pyrimidines
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1598349A1 Novel 2-pyridinecarboxamide derivatives
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598068A1 Antipsychotic heterocycle compounds
11/23/2005EP1597398A1 Tailored treatment suitable for different forms of mastocytosis
11/23/2005EP1597256A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
11/23/2005EP1597255A1 Rhodanine derivatives and pharmaceutical compositions containing them
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005EP1597252A1 Pyridine derivatives as fungicidal compounds
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 628